Fischer Imaging Announces Initial Shipments of Cedara-based SenoView(TM) Plus Softcopy Workstations; Installations at Leading Ho
30 Septiembre 2004 - 9:25AM
PR Newswire (US)
Fischer Imaging Announces Initial Shipments of Cedara-based
SenoView(TM) Plus Softcopy Workstations; Installations at Leading
Hospitals Across North America TORONTO, Sept. 30
/PRNewswire-FirstCall/ -- Fischer Imaging Corporation (FIMG:PK)
today announced that it has begun initial shipments of a new,
leading edge digital mammography workstation, the result of its
collaboration with Cedara Software Corp. (TSX:CDE/NASDAQ:CDSW). The
softcopy workstation, named SenoView Plus, is integrated with
Fischer's SenoScan(R) digital mammography system to provide
radiologists with powerful new capabilities for diagnosing breast
cancer. Hospitals that have installed or are about to install the
workstations include: Mt. Sinai Hospital, Marvelle Koffler Breast
Centre, Toronto; City Hospital, Martinsburg, West Virginia; and
Sansum Santa Barbara Medical Foundation Clinic, Santa Barbara, CA.
The SenoView Plus workstation will allow radiologists to compare
SenoScan digital mammography images and competitive FFDM images
with multi-modality images, such as ultrasound and MRIs. The
workstation's PACS-like design lends itself to reading studies from
all modalities with speed. The net result is the ability to deliver
optimal workflow and reading efficiency compared with traditional
film screen mammography systems with the added versatility of a
PACS review station. Fischer and Cedara teams were able to rapidly
integrate their respective systems as a result of the open
architecture of the SenoScan imaging platform. By producing images
in an industry-standard DICOM format SenoScan is open to leading
current and future complementary technologies assuring customers
maximum choice and flexibility. "Our open architecture assures
customers not only the freedom of choice they desire, but the
opportunity to achieve the highest possible performance from their
mammography operations," said Harris Ravine, Fischer Imaging
president and CEO. "Cedara brings powerful, specialized
multi-modality; digital workstation capabilities that will help
Fischer achieve its goal of providing the best total solution. I am
pleased by how rapidly our respective teams were able to complete
and assure the product offering and get it into our customers'
hands," said Ravine. For more information about Cedara, visit the
Cedara website at http://www.cedara.com/ or contact: Michelle
Pommells, Cedara Software Corp., (905) 672-2100 ext. 2356. Email: .
For investor-related inquiries, contact: Brian Pedlar, Chief
Financial Officer (905) 672-2100 ext. 2015 Email: About Fischer
Imaging Fischer Imaging Corporation designs, manufactures and
markets medical imaging systems for the screening and diagnosis of
disease. The company focuses on women's health, particularly the
diagnosis and screening of breast cancer through the application of
innovative digital imaging technologies. Fischer Imaging began
producing general-purpose x-ray imaging systems in 1910 and is the
oldest manufacturer of x-ray imaging devices in the United States.
For more information, visit http://www.fischerimaging.com/.
Contact: Michael Klatman, Resonant Communications (for Fischer
Imaging) 303-581-0509 About Cedara Software: Cedara Software Corp.
is a leading independent provider of medical technologies for many
of the world's leading medical device and healthcare information
technology companies. Cedara software is deployed in hospitals and
clinics worldwide - approximately 20,000 medical imaging systems
and 4,600 Picture Archiving and Communications System (PACS)
workstations have been licensed to date. Cedara is enabling the
future of the healthcare industry with new innovative approaches to
workflow, data and image management, integration, the web, software
components and professional services. The Company's medical imaging
solutions are used in all aspects of clinical workflow including
the capture of patient digital images; the sharing and archiving of
images; sophisticated tools to analyze and manipulate images; and
even the use of imaging in surgery. Cedara is unique in that it has
expertise and technologies that span all the major digital imaging
modalities including angiography, computed tomography (CT),
echo-cardiology, digital X-ray, fluoroscopy, mammography, magnetic
resonance imaging (MRI), nuclear medicine, positron emission
tomography (PET) and ultrasound. Certain statements contained in
this news release are forward-looking within the meaning of
securities laws and are based on current expectations that are
subject to a number of assumptions, uncertainties and risks, and
there are actual results may differ materially from what is
currently expected. These assumptions, uncertainties and risks
include, but are not limited to: the management of the growth of
the Company, dependence on key personnel of the Company,
competitive pressures (including price competition), changes in
market activity, risks associated with international operations,
the development of new products and services, the enhancement of
existing products and services, the introduction of competing
products having technological and/or other advantages, the
dependence on key customers, regulatory changes to the health care
industry, seasonality, economic and political conditions and
adequate protection of the proprietary interests of the Company.
Further information about these risks and uncertainties can be
found in the continuous disclosure documents filed from time to
time by Cedara with the securities regulatory authorities, which
documents are available at http://www.sedar.com/. All trademarks
appearing in this release are the property of Cedara Software Corp.
DATASOURCE: Cedara Software Corp. CONTACT: Michelle Pommells,
Director Product Communications, Cedara Software Corp., (905)
672-2100 ext. 2356, ; To request a free copy of this organization's
annual report, please go to http://www.newswire.ca/ and click on
reports@cnw.
Copyright